About this trial
This trial is studying a new way to help patients who are receiving CAR-T cell therapy. It focuses on using online tools to create personal plans for exercise and nutrition. Patients will get support from a team to follow these plans at home. The goal is to see how this approach can improve patients' quality of life and their overall health during and after treatment.
The trial's ID is NCT07390071. It is not in a specific phase but is focused on feasibility. It is not regulated by the FDA for drugs or devices. The trial hopes to include around 40 participants.
Who can join
Adults over 21 years old can join if they have lymphoma or myeloma and are starting CAR-T therapy in about four weeks. They should also have a good performance status and a working phone. Some people can't join if they have certain heart issues, are already in an exercise program, or are planning to move soon.
Conditions
Lymphoma, Myeloma, Cytokine Release Syndrome, Immune Effector Cell Associated Neurotoxicity Syndrome
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will use a special app and an internet-connected device to follow their exercise and nutrition plans. They will start this program four weeks before their CAR-T therapy and continue with it for 12 weeks after their hospital stay. Everyone in the trial will follow this plan together.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah